Article · 4 May 2026
ArticlePublished 17 May 2024
Exploring the Mechanism of Action of Yangxin Dingji Decoction in the Treatment of Atrial Fibrillation Based on Network Pharmacology
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Atrial fibrillation is a serious global public health risk. Conventional treatments for atrial fibrillation include surgery, pharmacologic cardioversion, anticoagulation, and ventricular rate control. There have been few studies on the treatment of atrial fibrillation by traditional Chinese medicine, and Yangxin Dingji decoction is one such traditional anti-arrhythmic herbal compound. However, there are few studies on its active ingredients and their possible mechanisms for the treatment of atrial fibrillation. We obtained the active chemical components of Yangxin Dingji decoction from different databases, analysed the bioavailability and pharmacodynamics of each active ingredient of Yangxin Dingji decoction using Swiss absorption, distribution, metabolism and excretion, and predicted its possible targets of action using traditional Chinese medicine systems pharmacology and SwissTargetPrediction. Then, we collected relevant targets of atrial fibrillation through DrugBank, therapeutic targets database, MalaCards, traditional Chinese medicine systems pharmacology, DisGeNet, and online mendelian inheritance in man. Based on this data protein-protein interaction networks were constructed. Finally, Metascape was systematically used to analyse the targets of Yangxin Dingji decoction intervention in atrial fibrillation. 213 active ingredients and 1191 Yangxin Dingji decoction targets were collected, and 362 atrial fibrillation-related targets were predicted, of which 18 intersected with Yangxin Dingji decoction targets. Molecular docking verified that Yangxin Dingji decoction can bind tightly to core targets. Based on the results of network pharmacology and enrichment analysis, we predicted that the main targets of Yangxin Dingji decoction intervention in atrial fibrillation which mainly treat atrial fibrillation through adrenergic signalling pathway, calcium signalling pathway, and voltage-gated potassium channel.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Shaochun Lu”
- BylineArticles whose byline prints “Lizhi Zhao”